NCT04857957: Safety, Tolerability & Pharmacokinetics Study of CNTX-6016 in Healthy Subjects and Subjects With PDN |
|
|
| Completed | 1 | 46 | US | Oral dose CNTX-6016 or oral dose Placebo | Centrexion Therapeutics | Painful Diabetic Neuropathy | 08/23 | 08/23 | | |
NCT05603754: A Study Utilizing Patient-Reported Outcomes to Evaluate the Safety and Efficacy of Lorecivivint (SM04690) for the Treatment of Moderately to Severely Symptomatic Knee Osteoarthritis (STRIDES) |
|
|
| Completed | 3 | 496 | US | Lorecivivint, SM04690, Placebo, Vehicle | Biosplice Therapeutics, Inc., NBCD A/S | Knee Osteoarthritis | 02/24 | 02/24 | | |
